FAKTOR OPTIONSSCHEIN - AMGEN | Market Closed - BOERSE MUENCHEN 03:45:38 2024-06-28 pm EDT | ||
| 6.5 EUR | 0.00% |
|
| Current month | -6.61% | ||
| 1 month | -3.85% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-06-28 | 6.5 | 0.00% |
| 24-06-27 | 6.5 | +0.93% |
| 24-06-26 | 6.44 | +6.10% |
| 24-06-25 | 6.07 | -2.41% |
| 24-06-24 | 6.22 | -7.16% |
Real-time BOERSE MUENCHEN
Last update June 28, 2024 at 03:45 pm EDT
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
UniCredit
|
| WKN | HD2VEF |
| ISIN | DE000HD2VEF0 |
| Date issued | 2024-02-21 |
| Strike | 418.3 $ |
| Maturity | Unlimited |
| Parity | 15.77 : 1 |
| Emission price | 10.24 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 12.86 € |
|---|---|
| Lowest since issue | 5.92 € |
| Spread | 0.01 € |
| Spread % | 0.15% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
312.4
USD
Average target price
316.4
USD
Spread / Average Target
+1.28%
- Stock Market
- Certificates
- Certificat
